Boehringer Ingelheim Venture Fund — Full Portfolio

ArrePath is a biotechnology company that applies AI/ML to drug discovery and development.

AI & Machine LearningBiotechDeep Tech

Zemer Gitai(Founder and SAB Chair)KKKevin Krause(President and Chief Executive Officer)

Co-investorsINInnospark VenturesINInsight Partners

DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.

BiotechDeep TechDigital HealthHealthtechMarseille, FR

BCBenjamin Charles(Co-Founder & CEO)inPCPatrick Collombat(Co-Founder & Scientific Advisor)inJean-Pascal Tranié(Co-Founder)in

Co-investorsADAdBio partnersRORoche Venture FundSUSunstone CapitalJDJDRF T1D Fund

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMSMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsANAngelini VenturesKUKurma PartnersCLClavystBioHIHighlight CapitalSESEEDS Capital

Obulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGhent, BE

Yves Briers(Scientific Founder)in

Co-investorsQBQbic Fund

Rewind Therapeutics is a biotech company focused on neurodegeneration and neuroimmune diseases, with leadership and scientific advisory expertise in drug discovery, clinical development, and translational research for conditions like multiple sclerosis and Alzheimer's disease.

BiotechDeep TechDigital HealthHealthtechMedical DevicesLeuven, BE

Jim Van Heusden(Executive Chair)Irene Knuesel(Chief Scientific Officer)Christophe Van Vaeck(Chief Financial Officer)Ricardo Hermosilla(Head of Translational Medicine)Stephen Burbidge(VP Preclinical Drug Development)

Co-investorsPMPMVM M VenturesSUSunstone Capital

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCOcoparionCRCreathor VenturesKUKurma PartnersTHThuja CapitalAPApollo Health Ventures

Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.

BiotechHealthtech

HFHugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)AMAlex Marshall(Chief Business Officer)in

Co-investorsEMEMBL VenturesGIGimvBIBioMedPartnersEPEpidarex Capital

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.

BiotechDeep TechHealthtechLongevityMedical Devices

MLMichael Luther(CEO)in

Co-investorsASAscension VenturesBRBreakout LabsBRBreakout VenturesDEDelos CapitalNYNYBC VenturesKDKdT Ventures+1 more

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer.

BiotechHealthtech

Co-investorsCOcoparionVEVentura BioMed InvestorsAPApollo Health Ventures

Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams.

AI & Machine LearningBiotechDigital HealthBerlin, DE

Frederick Klauschen(Founder)Maximilian Alber(Founder)Viktor Matyas(Founder)

Co-investorsCACARMA FUNDHTHTGFIBIBB VenturesMAMayo Clinic Ventures

Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.

RBRuben Boado(Founder)in

Co-investorsMIMitsui Global Investment

Asgard provides sales intelligence and intent detection data to B2B companies, identifying qualified prospects and their specific needs for targeted sales outreach and account-based marketing campaigns.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSales TechParis, FR

Co-investorsTETechstarsINIndustrifondenNONovo HoldingsRORobot Ventures

Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE

CPCristiana Pires(Co-founder and CEO)inFRFábio Rosa(Co-founder and VP of Research)inFPFilipe Pereira(Co-founder and Head of Innovation)in

Co-investorsINIndustrifondenLULU InnovationNONovo HoldingsRVRV Invest GmbH

Bodyport develops an FDA-cleared cardiac scale that non-invasively measures hemodynamic biomarkers through a patient's feet to detect early signs of worsening heart failure in a home setting.

Digital HealthHealthtechMedical DevicesWellness & FitnessSan Francisco, US

CCCorey Centen(Founder)inSSSarah Smith(Founder)in

Co-investorsHCHCVCINInitialized CapitalKAKapor CapitalPLPlayground GlobalSGSGH CapitalY Y Combinator+1 more

Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.

AI & Machine LearningDigital HealthMedical DevicesOxford, GB

MPMichalis Papadakis(CEO)inAlastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)

Co-investorsMOModi VenturesPAParkwalk Advisors

C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring.

Digital HealthHealthtechMedical DevicesCaparica, PT

Co-investorsNONovalis BiotechPOPortugal Ventures

Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsAMAMR Action FundNCNCL Technology Ventures Ltd.

Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.

BiotechDigital HealthHealthtechMedical DevicesNew York, US

DBDavid B. Klein(Founder and CEO)inRSRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)

BoardAlex Zisson(Director)

Co-investorsACAccelmed PartnersH.H.I.G. CapitalH.H.I.G. HealthBridge PartnersHEHealth Catalyst CapitalHIHikma VenturesRERevelation Partners+5 more

Delonix Group operates multiple hotel and experiential consumption brands across Asia-Pacific, leveraging AI and digital technology to drive member growth and innovation in hospitality.

ConsumerShenzhen, CN

郑郑南雁

Co-investorsININCE CapitalIDIDG CapitalZHZhenFund

Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways.

Digital HealthHealthtechMedical Devices

Co-investorsSESeventure Partners

Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.

BiotechDeep TechMedical DevicesNiel, BE

Co-investorsFUFund+PMPMVEQEQT Life SciencesNONovalis LifeSciencesOMOmega FundsPWPWV

EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).

BiotechDigital HealthLongevity

Robert Kirmeier(Founder)inWenzel von der Heydte(Founder)in

Co-investorsADAdBio partnersKHKhanuKUKurma Partners

HepaRegeniX is a clinical-stage biotech company developing therapies that treat acute and chronic liver diseases by promoting liver regeneration.

BiotechHealthtechTuebingen, DE

Co-investorsCOcoparionHTHTGFNONovo Holdings

Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease.

BiotechLongevityMedical Devices

Dr. Gill(Chief Scientific Officer)

Co-investorsDODolby Family VenturesEPEpidarex CapitalAMAMR Action Fund

BiotechPhoenix, US

Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)JRJason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)

Co-investorsXEXeraya CapitalB B Capital GroupCICity Hill VenturesDEDelos CapitalKOKorea Investment PartnersLULumira Ventures+1 more

Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsDIDigitalDx VenturesDEDesjardins CapitalHIHike VenturesZOZoic Capital

ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence.

BiotechHealthtechToronto

Juan Carlos Zuniga-Pflucker(Executive Officer, Director)

BoardFei Shen(Director)Ferdinand Massari(Director)

Co-investorsEIEisai Innovation, Inc.FAFACIT (Fight Against Cancer Innovation Trust)

Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.

BiotechDeep TechHealthtechLongevity

VBVictor Bustos(Co-Founder & CEO)inWLWolfgang Link(Scientific Co-founder & Advisor)inAPAndrew Pierce(Chief Science Officer)in

Co-investorsKOKorify CapitalAPApollo Health VenturesCOcoparionHTHTGF

Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

TWTravis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)ZWZhiping Weng(Co-founder)inSXSimon Xi(Co-founder and CEO)inJWJackie Walling(CMO)Debasish Roychowdhury(Director)

Co-investorsDEDelos CapitalVIVivo CapitalAMAMR Action FundKOKorea Investment PartnersLILilly Asia VenturesMAMatrix Capital Management+1 more

TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening.

BiotechHealthtechLongevity

Co-investorsLILifespan Vision Ventures